Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Patti Wins Sloan Research Fellowship

Published: Thursday, February 20, 2014
Last Updated: Wednesday, February 19, 2014
Bookmark and Share
Award honors outstanding early-career scientists.

The Alfred P. Sloan Foundation has announced Feb. 17th that WUSTL’s Gary Patti has been awarded a 2014 Sloan Research Fellowship. He is among 126 outstanding U.S. and Canadian researchers selected as fellowship recipients this year.

Awarded annually since 1955, the fellowships are given to early-career scientists and scholars whose achievements and potential identify them as rising stars, the next generation of scientific leaders.

“For more than half a century, the Sloan Foundation has been proud to honor the best young scientific minds and support them during a crucial phase of their careers when early funding and recognition can really make a difference,” said Dr. Paul L. Joskow, President of the Alfred P. Sloan Foundation. “These researchers are pushing the boundaries of scientific knowledge in unprecedented ways.”

“I am pleased and excited that Gary has been named a Sloan Fellow,” said William Buhro, PhD, professor and chair of chemistry. “Patti is a pioneer in the rapidly developing field of metabolomics, in which the wide arrays of small-molecule metabolites in biological systems are profiled. Metabolomics presents a massive data-analysis challenge, to which Gary is contributing new technologies. He is also applying his new metabolomics technologies to study the biochemistry of disease states, which will advance medical therapies.”

“The goal of metabolomics is to take a urine, blood or tissue sample, analyze it with an instrument called a mass spectrometer, and acquire a complete profile of all of the small molecules in the sample,” said Patti, PhD, assistant professor in the departments of chemistry, genetics and medicine. The profile might reveal whether the sample donor is ill, at risk of developing a disease, has been exposed to a toxin, or is unable to tolerate a drug therapy.

Metabolomics has already provided unparalleled insight into previously opaque illnesses, such as chronic pain. “We identified a molecule that, prior to our studies, was not known to be a naturally occurring compound. We have demonstrated that this molecule is an important player in mediating chronic pain, and this has opened up new avenues for therapies that could help millions of people,” Patti said.

His lab is also hot on the trail of sarcopenia, the muscle wasting that occurs in some elderly patients and leads to “fraility” that has also resisted scientific inquiry in the past. They identified six small molecules associated with aging in Caenorhabditis elegans, a worm that scientists use as a model system.

Two of these compounds change as a function of age in healthy human skeletal tissue and may be involved in sarcopenia. In the meantime the group is establishing a library of metabolite levels in long-lived model organisms.

Past Sloan Research Fellows include physicist Richard Feynman and game theorist John Nash. Since the beginning of the program in 1955, 42 fellows have received a Nobel Prize in their respective field, 16 have won the Fields Medal in mathematics, 13 have won the John Bates Clark Medal in economics, and 63 have received the National Medal of Science.

Scientists in eight scientific and technical fields-chemistry, computer science, economics, mathematics, evolutionary and computational molecular biology, neuroscience, ocean sciences, and physics-are eligible for the awards.

The fellowships are awarded through close cooperation with the scientific community. Candidates must be nominated by their fellow scientists, and winning fellows are selected by an independent panel of senior scholars on the basis of a candidate’s independent research accomplishments, creativity, and potential to become a leader in his or her field.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Chemical Emitted by Trees Can Impact Ozone Levels
Researchers have found that the way that isoprene, a natural hydrocarbon compound emitted from broadleaf deciduous trees, is processed in the atmosphere at night can have a big impact on the ozone in the atmosphere the next day.
Wednesday, May 18, 2016
Nanoparticles Present Sustainable Way to Grow Food Crops
Nanoparticle technology can help reduce the need for fertilizer, creating a more sustainable way to grow crops such as mung beans.
Tuesday, May 03, 2016
Living Off the Fat of the Land
Do cancer cells synthesize the parts for new cells or scavenge them from the environment?
Tuesday, April 05, 2016
Bacteria, Viruses in Gut Linked to Severity of HIV Infection
Intestinal microbes may speed progression from HIV to AIDS.
Monday, March 14, 2016
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Friday, February 05, 2016
Inherited Genetic Susceptibility Across 12 Cancer Types Uncovered
Researchers long have known that some portion of the risk of developing cancer is hereditary and that inherited genetic errors are very important in some tumors but much less so in others.
Tuesday, January 05, 2016
Genes Influence Choice
New research indicates that decision-making tendencies have a genetic link to brain pathways that underlie impulsivity and addiction disorders.
Thursday, December 10, 2015
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Tuesday, November 24, 2015
Combo of 3 Antibiotics Can Kill Deadly Staph Infections
Three antibiotics that, individually, are not effective against a drug-resistant staph infection can kill the deadly pathogen when combined as a trio, according to new research.
Tuesday, September 29, 2015
Gene Variant Linked to Smoking Longer, Getting Lung Cancer Sooner
Smokers with a particular variation in a nicotine receptor gene were more likely to continue smoking for four years.
Saturday, April 18, 2015
Personalized Melanoma Vaccines Marshal Powerful Immune Response
Vaccines target unique mutations in each patient’s tumor.
Wednesday, April 08, 2015
Protein that Rouses the Brain from Sleep May be Target for Alzheimer's Prevention
Scientists at Washington University have established links between sleep problems and Alzheimer’s.
Monday, November 24, 2014
Heart Drug May Help Treat ALS, Mouse Study Shows
Scientists blocked the enzyme in ALS astrocytes using digoxin, a medication used in the treatment of heart failure.
Wednesday, October 29, 2014
Study: Can Vitamin D Slow Heart Complications from Diabetes?
Researchers evaluate whether vitamin D can slow the development of cardiovascular problems in African Americans.
Thursday, May 15, 2014
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!